BioSpace News Archive

Reistone Biopharma Company Limited today announced the US FDA approval of IND for phase II clinical trial to investigate the efficacy and safety of selective Janus Kinase 1 inhibitor (JAK1) in moderate to severe ulcerative colitis (UC) in the United States.

The National Comprehensive Cancer Network’s Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers

Leading Oncologists Provide Practical, Clinical, and Economic Rationale for MRIdian MRI-Guided Radiation Therapy in the Treatment of Cancer

Showcasing eyecare devices and teleretinal solutions at the American Academy of Ophthalmology 2018 meeting, Canon U.S.A., Inc., a leader in digital imaging solutions, will provide attendees the opportunity to see how the Canon eyecare product portfolio can help improve their practice workflows and help them meet the retinal imaging needs of their patients.

Fresenius Kabi announced today the immediate availability in the United States of the Simplist® Palonosetron Hydrochloride Injection.

Scientific collaboration between RTI International and Asuragen leads to test validation

Drug Enforcement Agency (DEA) Places FDA-Approved Drug Containing CBD in Schedule V

CEI Vision Partners announces that Retina Physicians and Surgeons of Dayton, Ohio is now the newest partner practice of the CVP organization which was formed in May 2018.

Over 200 community leaders and business professionals gathered for the ceremonial opening of Sage Park Assisted Living and Memory Care in Kissimmee, Fla.

OWC Pharmaceutical Research Corp was administered in vivo in an animal model for the first time and was found to be safe and tolerable.